Skip to main content

Table 2 Risk of recurrence and CA-125 changes after the treatment

From: Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer

Variable

HR

95%CI

P

Change of CA-125 concentration

3 months after the treatment (U/ml)

< 0

1.00

0–5

1.25

0.80–1.93

0.3287

> 5

7.60

3.55–16.24

< 0.0001

Change of CA-125 concentration

6 months after the treatment (U/ml)

< 0

1.00

0–5

1.31

0.82–2.1

0.2598

> 5

5.29

2.99–9.35

< 0.0001